(15046889), K. E. H., (15046892), X. W., (15046895), J. S. R., (15046898), D. J. L., (15046901), N. E. S., (15046904), W. J. F., . . . (15046970), M. E. Y. (2025). Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models.
Citación estilo Chicago(15046889), Katie E. Hebron, et al. Supplementary Data File S6 from The Combination of Trametinib and Ganitumab Is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models. 2025.
Cita MLA(15046889), Katie E. Hebron, et al. Supplementary Data File S6 from The Combination of Trametinib and Ganitumab Is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models. 2025.
Warning: These citations may not always be 100% accurate.